The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5′ end of the PB2 segment  by Dos Santos Afonso, Emmanuel et al.
www.elsevier.com/locate/yviroVirology 341 (2The generation of recombinant influenza A viruses expressing a
PB2 fusion protein requires the conservation of a packaging
signal overlapping the coding and noncoding regions at the
5V end of the PB2 segment
Emmanuel Dos Santos Afonso, Nicolas Escriou, India Leclercq,
Sylvie van der Werf, Nadia Naffakh*
Unite´ de Ge´ne´tique Mole´culaire des Virus Respiratoires, URA CNRS 1966, Institut Pasteur, 25 rue du Dr. Roux, 75724 PARIS Cedex 15, France
Received 31 March 2005; returned to author for revision 25 April 2005; accepted 28 June 2005
Available online 9 August 2005Abstract
We generated recombinant A/WSN/33 influenza A viruses expressing a PB2 protein fused to a Flag epitope at the N- (Flag-PB2) or C-
terminus (PB2-Flag), which replicated efficiently and proved to be stable upon serial passage in vitro on MDCK cells. Rescue of PB2-Flag
viruses required that the 5V end of the PB2 segment was kept identical to the wild-type beyond the 34 noncoding terminal nucleotides. This
feature was achieved by a duplication of the 109 last nucleotides encoding PB2 between the Flag sequence and the 5VNCR. In PB2
minigenomes rescue experiments, both the 5V and 3V coding ends of the PB2 segment were found to promote the incorporation of
minigenomes into virions. However, the presence of the Flag sequence at the junction between the 3VNCR and the coding sequence did not
prevent the rescue of Flag-PB2 viruses. Our observations define requirements that may be useful for the purpose of engineering influenza
RNAs.
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The genome of influenza A viruses consists of eight
molecules of single-stranded RNA of negative polarity. The
viral RNAs (vRNAs) are associated with the nucleoprotein
(NP) and with the three subunits of the polymerase complex
(PB1, PB2 and PA) to form ribonucleoproteins (RNPs).
Once in the infected cells, the RNPs are transported to the
nucleus, where they undergo transcription and replication
(for a review, see Lamb and Krug, 2001). Export of the
newly synthesized RNPs from the nucleus to the cytoplasm
is mediated by the viral NEP (Nuclear Export Protein),0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: nnaffakh@pasteur.fr (N. Naffakh).which interacts with the RNPs most likely through the
matrix protein M1, and recruits the cellular factor Crm1
(reviewed in Cros and Palese, 2003). M1 plays a critical
role in cytoplasmic retention of recently exported RNPs
(Bui et al., 1996), and in the processes of virion assembly
and budding (for a review, see Nayak et al., 2004).
Complex association of NP and M1 proteins with cellular
cytoskeletal components could be involved in directing the
RNPs to the sites of viral assembly (Avalos et al., 1997;
Digard et al., 1999). Interaction of M1 with the RNPs on
the one side and with the cytoplasmic tails of the viral
glycoproteins on the other side seems to be required for
assembly and budding processes (Zhang et al., 2000). The
M2 integral membrane viral protein has recently been found
to play a role in genome packaging through its cytoplasmic
tail (Mc Cown and Pekosz, 2005). However, the mecha-005) 34 – 46
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particles remains unknown. Two models have been
proposed. According to the random packaging model, the
eight vRNA segments possess a common packaging signal,
and are incorporated randomly into viral particles. It is then
assumed that more than eight vRNAs can be incorporated
into a viral particle (Bancroft and Parslow, 2002; Enami et
al., 1991; Luytjes et al., 1989; Sekellic et al., 2000), and the
proportion of particles having acquired the full complement
of eight segments is predicted to be 2.8% for an average of
10 packaged vRNAs per particle (Enami et al., 1991). This
value is compatible with the ratios of infectious to
noninfectious particles found to be about 1 to 10% in
influenza viral stocks (Donald and Isaacs, 1954; van Elden
et al., 2001). The second model predicts the presence of
distinct packaging signals on each vRNA segment, leading
to the selective packaging of a set of eight different
segments into viral particles. The observation that short
defective-interfering (DI) RNAs with internal deletions in
the coding region compete specifically with their progenitor
RNA segment at the virion assembly step supports this
model (Duhaut and McCauley, 1996; Odagiri and Tashiro,
1997). More recently, Fujii et al., using reverse genetics,
demonstrated that the presence of the NA vRNA segment
(even if truncated so that it did not encode a functional NA)
was essential for efficient viral replication, and that both
ends of the NA vRNA coding region were required for
incorporation of the NA segment into virions (Fujii et al.,
2003). Similar findings were later reported for the HA and
NS segment (Fujii et al., 2005; Watanabe et al., 2003),
which is strongly in favor of a selective mechanism of
packaging, at least for some of the RNA segments.
However, the precise signals and mechanisms involved
are still to be understood.
Influenza virus segment #1 is 2341 nucleotides in length
and is one of the two largest genomic segments. It codes for
the 759 amino acids-long PB2 protein, a subunit of the
polymerase complex which is essential for viral mRNA
synthesis and also seems to play an important role in
replication of the viral genome (reviewed in Lamb and
Krug, 2001; Neumann et al., 2004). Its 3V and 5V noncoding
regions (NCRs) are 27 and 34 nt in length, respectively. The
12 and 13 nt at the extreme 3V and 5V ends, respectively, are
common to all segments and provide signals for vRNA
transcription and replication by the polymerase complex,
whereas the adjacent 15 and 21 noncoding nt are unique to
the PB2 segment. Duhaut and Dimmock have suggested that
the terminal 5V 150 nt is necessary for a defective segment
#1 to be replicated and/or packaged along successive
passages in cells infected with a helper virus (Duhaut and
Dimmock, 2000), and to show interfering properties
(Duhaut and Dimmock, 2002). We have investigated further
the presence of packaging signals at both extremities of the
PB2 segment, through attempts to generate recombinant
influenza viruses expressing a PB2 protein fused with a
peptidic tag, either at its C- or N-terminus.Results
Generation of recombinant influenza viruses expressing a
PB2 protein fused to the Flag peptide at the C-terminus
In order to generate recombinant A/WSN/33 viruses
expressing a modified PB2 protein, we used reverse genetics
based on the set of plasmids described by Fodor et al.
(1999): eight plasmids from which each of the genomic
vRNAs is transcribed by RNA polymerase I (pPolI
plasmids) and four additional plasmids expressing the
nucleoprotein NP and the polymerase proteins PB1, PB2
and PA. The pPolI-PB2 plasmid was modified so that it
would produce the PB2-Flag RNA (Fig. 1A), where the
sequence encoding the Flag peptide is fused to the sequence
encoding the C-terminus of PB2, at the junction with the
5VNCR. The resulting plasmid was modified further, based
on the observations of Duhaut and Dimmock which
suggested that the terminal 5V 150 nt was necessary to
achieve stable passage of the PB2 segment (Duhaut and
Dimmock, 2000). A duplication of the last 109 nt encoding
PB2 was inserted between the stop codon of the PB2-Flag
sequence and the 5VNCR. The resulting PB2-Flag-143 RNA
is identical to the wild-type (wt) PB2 RNA for the terminal
5V 143 nt, whereas the PB2-Flag RNA shares only the
terminal 5V 37 nt (34 nt from the 5VNCR and 3 nt from the
adjacent stop codon) with the wt PB2 RNA (Fig. 1A). As
we were concerned by the possibility that such a segment
could be too long to be efficiently packaged, we generated
two intermediate constructs, to produce the PB2-Flag-95
and PB2-Flag-70 RNAs which maintain a 5V end identical to
the PB2 segment on 95 and 70 nt, respectively (Fig. 1A).
Another concern was the possibility that modifying the
length of the PB2 segment could interfere with the process
of encapsidation with the NP protein. Observations by
Ortega et al. suggest that the NP protein interacts as a dimer
with 48 nt (Ortega et al., 2000). Thus, the pPolI-PB2-Flag-
143 and PB2-Flag-95 plasmids have been designed such
that the length of the corresponding RNAs is increased by a
multiple of 48 nt as compared to the wt PB2 segment, which
will be referred to below as ‘‘the rule of 48 nt’’.
To control that correct expression of the PB2-Flag fusion
protein could be obtained from this series of constructs, the
sequences of the wt or modified PB2 segments were
subcloned in positive-sense orientation into plasmid
pcDNA3.1, under the control of the CMV promoter. The
resulting pcDNA-PB2-wt and pcDNA-PB2-Flag plasmids
were transfected into COS-1 cells, and total cell extracts
were analyzed by Western blot. Similar levels of the PB2
and PB2-Flag proteins were detected using an anti-PB2
polyclonal antibody (Fig. 2A, lanes 2 and 3), and the PB2-
Flag protein was also revealed using an anti-Flag antibody
(Fig. 2B, lane 3). The pcDNA-PB2 plasmids where
subsequently transfected in COS-1 cells together with the
pcDNA-WSN-PB1, -PA, and -NP plasmids, and with the
pPR7-FluA-CAT plasmid which directs transcription of an
Fig. 1. Schematic representation of A/WSN/33 virus-derived PB2 vRNA segments used in reverse genetics experiments. The wild-type PB2 vRNA (top) as
well as vRNAs encoding a PB2-Flag (A), a Flag-PB2 (B) or a PB2-GFP (C) fusion protein are represented schematically. The PB2-ORF (light grey boxes) is
fused to the sequences encoding the Flag peptide or the GFP protein (dark grey boxes) and flanked by the 3V and 5VNCRs (black lines). The duplicated PB2-
ORF sequences are represented as hatched boxes, and the length of the sequence kept identical to the wt PB2 vRNA at the extremity is indicated by a
doubleheaded arrow. The 2A cleavage site is represented as a white box. The stop codons are indicated by black arrowheads.
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et al., 1999). The efficiency of transcription/replication of
the pseudo-viral RNA was monitored by measuring CAT
levels in cytoplasmic cell extracts at 24 h post-transfection.
As shown in Table 1, CAT levels measured when the
complex was reconstituted with a PB2-Flag protein were
about 50–70% of those measured in the presence of a wt
PB2, which indicated that the presence of the tag at the C-
terminus of PB2 slightly decreased the transcription/
replication activity of the complex.
Given these results, we used reverse genetics to compare
the efficiency of production of viruses expressing the various
PB2-Flag segments. Cocultures of 293T and MDCK cells
were transfected with the wt pPolI-PB2 or modified pPolI-
PB2-Flag constructs, together with the 11 other plasmids
required, as described under Materials and methods. Two
independent clones of each type of pPolI-PB2-Flag plasmid
were tested. Plaque assays were performed to test for the
presence of infectious viruses in the transfection supernatants
(P0). Recombinant viruses were subsequently passaged on
MDCK cells at low m.o.i. (0.001) for up to 5 passages. Virustiters at P0 and P2 as well as plaque size at P2 are recorded in
Table 1. At each passage, the presence of the sequences
inserted at the junction between the coding region and the
5VNCR was verified. To this end, viral RNA was extracted,
and subjected to RT-PCR and direct sequencing of the PCR
products, using primers designed to amplify the whole region
of insertion (Fig. 3B). The results are summarized in Table 1
(far right column). When the pPolI-PB2-Flag plasmid was
used, virus was detected in the transfection supernatant in one
assay out of two. Following two passages on MDCK cells,
the titer was about 107 pfu/ml, 5-fold lower than the titer
observed with the wt pPolI-PB2 plasmid (Fig. 3A; Table 1).
However, subsequent analysis of the PB2 vRNA by RT-PCR
and sequencing revealed that deletion of the Flag sequence
had occurred (Fig. 3B) and the sequence at the junction
between the 5VNCR and the coding sequence had reverted to
the wt, in agreement with the wt plaque size of this virus (Fig.
3A). When the pPolI-PB2-Flag-70 plasmid was used, one
assay generated revertant viruses with a wt-like PB2 segment,
but the second assay allowed recovery at a low titer (about
103 pfu/ml) of viruses forming small-sized plaques as
Fig. 2. Western blot analysis of the steady-state level of expression of PB2 fusion proteins. Whole cell extracts were prepared from COS-1 cells transfected with
the PB2 expression constructs as indicated, loaded on a 10% (PB2-Flag and Flag-PB2 constructs) or a 8% (PB2-GFP and GFP-PB2 constructs) polyacrylamide
gel, and analyzed by Western blotting as described under Materials and methods, using either a polyclonal antibody directed against the PB2 protein (A) or
monoclonal antibodies specific for the Flag epitope or the GFP protein (B). A cell extract prepared from COS-1 cells transfected with the pEGFP-N1 plasmid
(Clontech) was used as a positive control for detection of the GFP protein (lane 13). Black arrowheads: PB2 wt or fusion proteins; open arrowhead: GFP
protein.
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RT-PCR products demonstrated that the Flag coding
sequence and the PB2-ORF duplication were present,
even after two passages on MDCK cells (Fig. 3B). Very
similar results were obtained when the pPolI-PB2-Flag-95
plasmid was used, although remarkably the small plaque-
forming virus generated from pPolI-PB2-Flag-95 grew at
higher titers (about 107 pfu/ml) as compared to those
issued from pPolI-PB2-Flag-70 (data not shown, Table 1).
Finally, in the two assays using the pPolI-PB2-Flag-143
plasmid, large plaque-forming viruses were obtained with
high titers in the range of 108 pfu/ml (Table 1, Fig. 3A).
After being subjected to 5 successive passages on MDCK
cells, these viruses still retained the whole Flag sequence
and PB2-ORF duplication at the junction with the 5VNCR
of the PB2 segment (Fig. 3B). On the whole, these
results indicated that insertion of the Flag sequence at the
junction between the 5VNCR and PB2-ORF disrupted a
signal (extending from the 5VNCR upstream to some-
where between nt 95 and nt 143) which was essential for
replication and/or packaging of the PB2 segment.
The growth properties of the PB2-Flag-143 virus were
further examined. MDCK cells were infected at an m.o.i. of
0.001, and virus titers in the culture supernatant were
determined at different times post-infection by plaque assay
on MDCK cells. The growth curves of the PB2-Flag-143
and PB2 wt recombinant viruses were very similar,
maximum titers of 5–10  107 pfu/ml being observed at
48 h post-infection. In the case of the PB2-Flag-95recombinant virus, a slow-down in the growth kinetics
was observed after 24 h of infection and titers did not
exceed 1.3  106 pfu/ml (Fig. 3C). Expression of the PB2-
Flag protein in MDCK cells infected with the PB2-Flag-143
virus was detected in the nucleus by indirect immunofluor-
escence assay using an anti-Flag antibody whereas in the
same cells the NP was found to localize in both the nucleus
and cytoplasm of infected cells (Fig. 3E).
Generation of recombinant influenza viruses expressing a
PB2 protein fused to the Flag peptide at the N-terminus
A similar approach was used in order to investigate
sequence requirements at the 3V end of the PB2 segment for
the generation of a recombinant A/WSN/33 virus stably
expressing a PB2 protein fused to the Flag peptide at the N-
terminus. The pPolI-PB2 plasmid was modified to produce
either the Flag-PB2, 117-Flag-PB2 or 165-Flag-PB2 RNAs,
which are identical to the wt PB2 segment for the 3V
terminal 27, 117 or 165 nt, respectively (Fig. 1B). For 117-
Flag-PB2 and 165-Flag-PB2 plasmids, the length of the
duplicated sequences was selected in accordance with the
‘‘rule of 48 nt’’ as defined earlier. The 2A autocatalytic
cleavage site derived from the FMDV virus (Donnelly et al.,
1997) was inserted at the junction between these duplicated
sequences which encode the 30 and 46 N-terminal amino
acids of PB2, respectively, and the Flag sequence. Expres-
sion of the Flag-PB2 fusion proteins was tested as described
above for the PB2-Flag proteins. As shown in Fig. 2, the
Table 1
Characterization of the recombinant viruses obtained by reverse genetics
PB2 vRNA Size
(nt)
CAT levels
(%)a
Clone # P0 viral titer
(pfu/ml)
P2 viral titer
(pfu/ml)
Plaque sizeb Genotype
stabilityc
PB2-wt 2341 100 1 3.7  108 3.5  108 L +
PB2-Flag 2371 71 T 11 1 NAd NA NA NA
2 2  105 1.7  107 L 
PB2-Flag-70 2412 57 T 1.1 1 1.2  107 2.5  107 L 
2 2.3  103 1.5  105 S +*
PB2-Flag-95 2437 60 T 33 1 2  107 2.7  107 S +*
2 7.5  106 4.7  108 L 
PB2-Flag-143 2485 53 T 5.5 1 2.5  108 1.2  108 L +**
2 9.7  107 7.2  108 L +***
PB2-wt 2341 100 1 1.7  107 1.5  108 L +
Flag-PB2 2371 32 T 5.4 1 1  104 7.2  107 L +**
2 2.5  104 9.0  107 L +
117-Flag-PB2 2533 23 T 0.3 1 7.7  105 6.3  107 L +
2 9  105 7.5  107 L +
165-Flag-PB2 2581 33 T 2.8 1 3.2  106 7.2  107 L +**
2 3.5  106 4  107 L +
PB2-wt 2341 100 1 7  108 2  108 L +
PB2-GFP-166 3205 30 T 4.1 1 NA NA NA NA
2 NA NA NA NA
PB2-stop-GFP-166 3205 65 T 5.4 1 7.5  106 1.5  106 S+L 
2 1.5  106 3.0  106 S +
111-GFP-PB2 3253 5 T 5 1 NA NA NA NA
2 NA NA NA NA
159-GFP-PB2 3301 11 T 3.9 1 NA NA NA NA
2 5  104 NDe L 
a Extracts from COS-1 cells transfected with the pcDNA-PB2 plasmids corresponding to the indicated PB2 vRNAs in combination with plasmids pcDNA-
PB1, -PA, -NP and pPR7-FluA-CAT were analyzed at 24 h post-transfection by ELISA for the level of CAT, as described under Materials and methods. CAT
levels are expressed as percentage values (100% = value measured with the wt PB2 vRNA) and as the average T SEM from duplicate samples.
b L: large; S: small. Plaque size is as observed at P2, except for virus 159-GFP-PB2 (P0).
c Genotype stability was examined by RT-PCR and sequencing as described under Materials and methods. Reversion to the wt genotype is indicated by ‘‘’’
stability of the recombinant genotype is indicated by ‘‘+’’ as analyzed up to passage 5, passage 2 (*) or passage 8 (**). (***)Reversion to the wt genotype was
observed at passage 7.
d NA: not applicable, as no virus was recovered.
e ND: not done.
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higher levels than the wt PB2 protein (Fig. 2A, lanes 2 and 4
to 6), and could be detected using the anti-Flag antibody
(Fig. 2B, lanes 4 to 6). The proteins expressed from the 117-
Flag-PB2 and 165-Flag-PB2 constructs appeared to be
efficiently cleaved at the 2A site, as for the major part,
they migrated at the same position as the protein expressed
from the Flag-PB2 construct (Figs. 2A and B, lanes 5 and
6). When polymerase complexes were reconstituted in the
presence of the Flag-PB2 proteins in the transient tran-
scription/replication assay described above, CAT levels
were about one third of those measured in the presence of
a wt PB2 (Table 1), and about one half of those measured in
the presence of a PB2-Flag protein.
The efficiency of production of viruses expressing the
various Flag-PB2 segments was compared. Transfections
were performed using two independent clones of each of the
pPolI-Flag-PB2, pPolI-117-Flag-PB2 or pPolI-165-Flag-
PB2 plasmids, in parallel with the pPolI-PB2 plasmid.
Results are summarized in Table 1. In all cases, large
plaque-forming viruses were obtained. Titers in the reverse
genetics supernatant were about 1–2  104, 7–9  105 and3  106 pfu/ml for the Flag-PB2, 117-Flag-PB2 and 165-
Flag-PB2 viruses, respectively, as compared to 107 pfu/ml
for the PB2 wt virus. This gradual increase suggested a
possible correlation between the length of duplicated
sequences and the fitness of recombinant viruses. How-
ever, following 2 passages at low m.o.i. on MDCK cells,
all recombinant Flag-PB2 expressing viruses grew up to
titers of 4–9  107 pfu/ml. The viral stocks were passaged
three more times on MDCK cells at a low m.o.i.. RT-PCR
analysis of the PB2 segment at passage 5 indicated that the
inserted Flag sequence and PB2-ORF duplication were still
present, in all viral stocks (data not shown, Table 1).
Growth curves were carried out by infecting MDCK cells
at an m.o.i. of 0.001 with the Flag-PB2, 117-Flag-PB2 or
165-Flag-PB2 viruses, in parallel with the PB2 wt virus.
Very similar kinetics of multiplication were observed,
maximum titers (1–2  108 pfu/ml for Flag-PB2 express-
ing viruses, 7  108 pfu/ml for the wt virus) being reached
at 48 h post-infection (Fig. 3D). Expression of the Flag-
PB2 protein in MDCK cells infected with the Flag-PB2
virus was detected in the nucleus by indirect immuno-
fluorescence assay using an anti-Flag antibody (Fig. 3E).
Fig. 3. Multiplication and stability of recombinant A/WSN/33 influenza viruses with PB2 segments encoding a PB2-Flag fusion protein. (A) The titers and
plaque phenotype of the indicated recombinant viruses were determined on P2 supernatants using a standard plaque assay on MDCK cells, as described under
Materials and methods. Crystal violet staining of cell monolayers is shown for one or two independent clones (C1, C2). Revertant viruses (rev) are indicated.
(B) Genetic stability of the recombinant viruses was tested by multiple passages on MDCK cells at an m.o.i. of 0.001. The viral RNAs from one or two
independent clones (C1, C2) of the indicated viruses were analyzed by RT-PCR using the PB2/+/1772 and PB2//5VNCR oligonucleotides. The position of the
primers is indicated by arrows on a schematic drawing of the PB2-Flag-143 vRNA. Amplification was performed in parallel on the corresponding plasmid
DNA (D), on RNA from the supernatant of mock-infected cells (M) and on water (<). The amplified products were analyzed on a 1% agarose gel and
visualized by ethidium bromide staining. The results obtained for the first (P1) and last (P2 or P5) passages of the indicated viruses are shown. MW: DNA
molecular weight marker. The growth curves of the PB2-wt, PB2-Flag-95 and PB2-Flag-143 (C) or PB2-wt, Flag-PB2, 117-Flag-PB2 and 165-Flag-PB2 (D)
recombinant viruses were compared. Confluent monolayers of MDCK cells were infected at an m.o.i. of 0.001. At the indicated time points, the supernatants
were harvested, and virus titers were determined on MDCK cells in a standard plaque assay. (E) Nuclear expression of the PB2-Flag and Flag-PB2 proteins was
detected in MDCK cells infected with the PB2-Flag-143 and Flag-PB2 recombinant viruses, using an indirect immunofluorescence assay. MDCK cells were
infected at an m.o.i. of 10 with the PB2-wt, PB2-Flag-143 virus or Flag-PB2 virus, or mock-infected. At 6 h post infection, cells were stained as described
under Materials and methods, using either an anti-NP or an anti-Flag monoclonal antibody.
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Flag sequence at the junction between the PB2-ORF and
3VNCR did not disrupt a signal essential for replication and/or
packaging of the PB2 segment, unlike what was observed
when the insertion was at the junction with the 5VNCR.
Effect of fusion of the GFP sequence to PB2 on the
generation of recombinant influenza viruses
Based on the observations described above, we attempted
to generate recombinant viruses expressing a PB2 protein
fused to the GFP protein. Indeed, Fodor and Smith (2004)
have found that the PB2 protein of WSN was active in a
transient transcription/replication assay when fused to the
GFP tag. The pPolI-PB2 plasmid was modified so that it
would produce the PB2-GFP-166 RNA, analogous to the
PB2-Flag-143 RNA. To this end, the sequence encoding the
GFP was fused to the sequence encoding the C-terminus of
PB2, and a duplication of the last 132 nt encoding PB2 was
inserted at the junction between the GFP and the 5VNCR
sequences, resulting in a 5V end of the PB2 segment identical
to the wt on 166 nt (Fig. 1C). The pPolI-111-GFP-PB2 and
pPolI-159-GFP-PB2 plasmids were also constructed, analo-
gous to the pPolI-117-Flag-PB2 and pPolI-165-Flag-PB2
plasmids. In all three pPolI-PB2-GFP-166, -111-GFP-PB2
and -159-GFP-PB2 plasmids, the length of the duplicated
sequences was selected according to the ‘‘rule of 48 nt’’. The
sequences corresponding to the modified PB2 segments
were subcloned in positive-sense orientation into plasmid
pcDNA3.1, and expression of the GFP fusion proteins was
analyzed by Western blot. The PB2-GFP protein accumu-
lated in transfected COS-1 cells at levels equivalent to those
observed for the wt PB2 protein (Fig. 2A, lanes 8 and 9),
whereas the GFP-PB2 proteins accumulated at much higher
levels (Fig. 2A, lanes 8 and 11–12). Both PB2-GFP and
GFP-PB2 proteins could be detected using an anti-GFP
antibody (Fig. 2B, lanes 9 and 11–12). The proteins
expressed from the 111-GFP-PB2 and 159-GFP-PB2 con-
structs appeared to be efficiently cleaved at the 2A site, as for
the major part they migrated at the same position as the
protein expressed from the PB2-GFP construct (Figs. 2A and
B, lanes 9 and 11–12). Noticeably, when the anti-GFP
antibody was used, a polypeptide migrating at a position
close to GFP was detected along with the PB2-GFP or GFP-
PB2 proteins (Fig. 2B, lane 9 and 11–12, open arrowhead),
which most likely resulted from degradation and/or from
internal initiation events. When polymerase complexes were
reconstituted in the presence of the PB2-GFP or GFP-PB2
proteins in the transient transcription/replication assay, CAT
levels were 30 and 5–11% of those measured in the presence
of a wt PB2, respectively (Table 1). Thus, in the presence of
the GFP protein fused at the C-terminus of PB2 and even
more so when GFP was fused at the N-terminus of PB2, the
transcription/replication activity of the polymerase complex
was decreased more significantly than for their PB2-Flag or
Flag-PB2 counterparts.The efficiency of production of viruses expressing the
PB2-GFP or GFP-PB2 segments was compared. Trans-
fections were performed using two independent clones of
each of the pPolI-PB2-GFP-166, pPolI-111-GFP-PB2 or
pPolI-159-GFP-PB2 plasmids, in parallel with the pPolI-
PB2 plasmid. Supernatants tested at 48 h post-transfection
contained either no virus, or revertant viruses having lost all
of the GFP and PB2-ORF duplication sequences (Table 1).
We tested whether the rescue of PB2-GFP-166 viruses could
be prevented by the large size of PB2-GFP-166 vRNA (3205
nt, as compared to 2341 nt for the wt). To this end, we
modified the pPolI-PB2-GFP-166 plasmid, by replacing an
Alanine codon at the junction between the PB2 and GFP
sequences with a stop codon. The resulting PB2-stop-GFP-
166 RNA (Fig. 1C) has exactly the same size as the PB2-
GFP-166 RNA, but encodes a wt PB2 instead of a PB2-GFP
fusion protein, as confirmed by Western blot analysis (Figs.
2A and B, lane 10) and significant recovery of activity in the
transcription/replication assay (Table 1). Transfection of the
pPolI-PB2-stop-GFP-166 plasmid yielded revertant viruses
having lost the PB2-ORF duplication and most of the GFP
sequences in one assay. But in a second independent assay, it
resulted in moderate titers (about 106 pfu/ml) of small plaque-
forming viruses, which carried the whole GFP and PB2-ORF
duplication sequences, and remained phenotypically and
genotypically stable along 5 successive passages on MDCK
cells at low m.o.i. (Table 1). These observations suggested
that the large size of the PB2-GFP-166 segment albeit limiting
the efficiency of rescue of recombinant viruses was not totally
preventing the rescue. The combination of the large size of the
recombinant PB2 segment and the low activity of the
polymerase complex with the PB2-GFP protein could account
for the failure in rescuing any PB2-GFP-166 virus. Yet, the
presence of the GFP protein fused to the C-terminus of PB2
could also interfere with other steps in the viral life cycle,
such as PB2 import into the nucleus or RNP trafficking.
Transcription/replication and incorporation of PB2
minigenomes into viral particles
Based on the results obtained in the reverse genetics
experiments described above, we examined more precisely the
role of the sequences at the 3V and 5V end of the PB2 segment
in replication and packaging of the vRNA. To this end, we
used an influenza minigenome/helper virus system which
allows to differentiate the transcription/replication step from
later steps of the viral cycle (Leclercq et al., manuscript in
preparation). We constructed four pPolI plasmids producing
influenza PB2 minigenomes (represented schematically in Fig.
4A): pPolI-PB2(27)GFP(34), which contains the 3V and
5VNCRs of the PB2 segment flanking the GFP coding
sequence in positive sense orientation; pPolI-PB2(159)
GFP(34), which contains 132 additional nt corresponding to
the N-terminal PB2 coding region adjacent to the 3VNCR;
pPolI-PB2(27)GFP(166) which contains 132 additional nt
corresponding to the C-terminal PB2 coding region, cloned
Fig. 4. Analysis of influenza PB2 minigenomes. (A) Schematic representation of influenza PB2 minigenomes. Each minigenome contains the GFP-ORF
(hatched bar, not on scale), flanked by the 27 nt of the 3V noncoding region and 34 nt of the 5V noncoding region derived from the PB2 vRNA (black bars). The
PB2 coding regions (grey bars) correspond to the first 132 nt of the PB2-ORF (inserted downstream of the 3V noncoding region and in frame with the GFP-
ORF) and to the last 132 nt of the PB2-ORF (inserted between the stop codon of the GFP-ORF and the 5V non coding region). The stop codons are indicated by
black arrowheads. (B) Schematic representation of the experimental protocol used to test the efficiency of incorporation of PB2 minigenomes into viral
particles, as described under Materials and methods. (C) The percentages of GFP-expressing cells measured among COS-1 cells transfected with the
minigenomes and superinfected with the helper A/WSN/33 virus at an m.o.i. of 2 or 0.02, and among MDCK cells infected with the supernatant of COS-1
cells, are indicated. The results of one representative experiment out of three are shown.
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and pPolI-PB2(159)GFP(166), which contains both extended
3V and 5V extremities. In plasmids pPolI-PB2(159)GFP(34) and
pPolI-PB2(159)GFP(166), no cleavage site was inserted
between the PB2-ORF duplication and the GFP sequence.
As a consequence, these constructs direct the expression of a
GFP protein fused to the first 44 amino acids of PB2 at the N-
terminus. In order to estimate the efficiency with which the
PB2 minigenomes were undergoing transcription/replication
and were incorporated into virions, COS-1 cells were trans-
fected with each of the four pPolI plasmids separately, and
infected 24 h later with A/WSN/33 virus at an m.o.i. of 2. In
these conditions, more than 90% of the cells were infected, as
indicated by indirect immunostaining with a monoclonal
antibody specific for the NA protein of A/WSN/33 virusand flow cytometry analysis (data not shown). At 24 h post-
infection, both the cells and supernatants were harvested (Fig.
4B). The COS-1 cells were tested for GFP expression,
predicted to result from transcription and replication of the
GFP minigenomes by the polymerase complex of the A/WSN/
33 helper virus. The supernatants were used undiluted to infect
MDCK cells which were analyzed for expression of GFP at 24
h post-infection. The results are shown in Fig. 4C. The levels
of fluorescence measured in COS-1 cells were very low,
suggesting that GFP minigenomes derived from RNA
Polymerase I transcription may not constitute optimal tem-
plates for transcription/replication by the helper virus. About
4–5% of COS-1 cells showed fluorescence above the
background when they had been transfected with pPolI-
PB2(27)GFP(34) or pPolI-PB2(27)GFP(166). This percent-
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COS-1 cells had been transfected with pPolI-PB2(159)GFP
(34) or pPolI-PB2(159)GFP(166). This difference could
likely reflect a decreased expression or stability of the GFP
protein when fused to PB2-derived amino acids at its N-
terminus, although some difference in the efficiency of
transcription/replication of the minigenomes cannot be
excluded. In MDCK cells infected with COS-1 supernatants,
a small but significant percentage of GFP positive cells (2%)
was obtained only when the cells had been initially transfected
with pPolI-PB2(159)GFP(166).When an m.o.i. of 0.02 instead
of 2 was used to superinfect COS-1 cells with the A/WSN/33
helper virus, about 25% MDCK cells were found to express
GFP upon infection with the supernatant of COS-1 cells
transfected with this pPolI-PB2(159)GFP(166) plasmid (Fig.
4C). In contrast, when COS-1 cells had been transfected with
any of the pPolI-PB2(27)GFP(34), pPolI-PB2(159)GFP(34) or
pPolI-PB2(27)GFP(166) plasmids, no significant GFP expres-
sion was detected in MDCK cells upon infection with the
COS-1 cells supernatants (Fig. 4C). These data strongly
suggested that not only sequences at the 5V but also sequences
at the 3V end of the PB2-ORF were needed in addition to the 5V
and 3VNCR in a phase of the viral cycle subsequent to
transcription/replication and for efficient incorporation of the
PB2 minigenome into virions. This interpretation is compat-
ible with the difference observed when helper virus infection
was performed at high or low m.o.i.. As mentioned above,
upon infection at an m.o.i. of 2, COS-1 cells that had been
transfected with pPolI-PB2(159)GFP(34) or pPolI-PB2(159)
GFP(166) both showed a lower percentage of GFP-positive
cells than with pPolI-PB2(27)GFP(166) or pPolI-
PB2(27)GFP(34). When an m.o.i. of 0.02 was used, this
percentage remained lower for COS-1 cells that had been
transfected with pPolI-PB2(159)GFP(34), but not with pPolI-
PB2(159)GFP(166). The difference is most likely due to the
propagation of the PB2(159)GFP(166) minigenome on COS-1
cells along multiple cycles of viral multiplication, which could
occur only when the helper virus was used at a low m.o.i.
Our observations about the 5V end requirement for
minigenomes propagation were in agreement with the fact
that the 5V end of the PB2 segment had to be kept identical to
the wt beyond the 34 noncoding terminal nucleotides for PB2-
Flag viruses to be successfully rescued. Noticeably, mini-
genome propagation also required the presence of the 3V end of
the PB2 segment beyond the 27 noncoding terminal nucleo-
tides. This result was in contrast with the fact that Flag-PB2
viruses were efficiently rescued, although the 3V end of their
PB2 segment was identical to wt for the 27 noncoding terminal
nucleotides only.Discussion
In this study, we have generated recombinant WSN
influenza viruses expressing a PB2 protein fused to a Flag
epitope at the C- or N-terminus. Such viruses couldrepresent useful tools to investigate the molecular inter-
actions involving PB2 during the viral multiplication cycle,
by immunoprecipitation assays or immunofluorescence co-
localization experiments. In addition, engineering the PB2
segment gave us some insights into the sequence signals and
length constraints involved in replication and packaging of
this specific genomic segment.
In order to generate a recombinant virus stably express-
ing a PB2 protein fused with a Flag epitope at the C-
terminus, it appeared necessary to keep the 5V end of the
PB2 segment identical to the wild-type for more than the
34 noncoding terminal nucleotides. This was achieved by
inserting into the pPolI-PB2 plasmid a duplication of the
36, 61 or 109 last nucleotides encoding PB2, between the
Flag and 5VNCR sequences. As a result, recombinant
viruses were isolated whose segment #1 included an ORF
encoding a PB2-Flag protein, and a 5V end identical to the
wt for 70, 95 or 143 nt, respectively (PB2-Flag-70, PB2-
Flag-95, PB2-Flag-143 viruses, respectively). In the same
conditions, PB2-Flag viruses with a PB2 segment identical
to the wt at the 5V end for the 37 nt only (34 nt from the
5VNCR and 3 nt from the adjacent stop codon), could not
be generated. These results indicate that the presence of the
stretch of the terminal 5V 70 nt instead of the terminal 5V 37
nt is enough to increase the efficiency of rescue of the
modified PB2 segment. However, the PB2-Flag-70, and to
a lesser extent the PB2-Flag-95 virus, had reduced growth
capacities as compared to the wt virus, and had a tendency
to revert to the wt PB2 sequence with a high frequency.
Reversion probably occurred during RNA replication, and
conferred such a selective advantage that the revertant
genotype became predominant. In contrast, the PB2-Flag-
143 virus had growth characteristics very similar to the wt
virus, and was genotypically stable for up to five passages
on MDCK cells at low m.o.i. These observations are in
agreement with previous reports by Duhaut and Dimmock,
which suggested that the terminal 5V 150 nt was necessary
for a defective PB2 segment to be replicated and/or
packaged along successive passages in cells infected with
a helper virus (Duhaut and Dimmock, 2000, 2002). The
present study provides additional information about the
signals contained within the terminal 5V nt of the PB2
segment. First, our data indicate that these signals are
overlapping the 5VNCR and the sequence encoding the C-
terminus of PB2. Indeed, in the PB2-Flag construct which
did not allow recovery of recombinant viruses, both these
noncoding and coding regions were present but they were
separated by the Flag sequence. Second, the intermediate
phenotype of PB2-Flag-95 viruses, as compared to PB2-
Flag-70 and PB2-Flag-143 viruses, suggests a correlation
between the length of the sequences conserved at the 5V end
of the PB2 segment and the capacity of multiplication of
the resulting viruses. This correlation with length supports
the hypothesis that a signal consisting of a linear sequence,
or formed by a succession of small secondary structures, is
present at the 5V end of the PB2 segment rather than a
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143 nt. Third, our data from PB2-minigenomes rescue
experiments strongly suggest that the presence of the
terminal 5V 166 nt does not increase the efficiency with
which the PB2 segment undergoes transcription/replication,
but promotes later steps of the viral cycle, such as
incorporation of the PB2 segment into viral particles.
These results are in agreement with recent publications
showing that the ends of the NA, HA and NS vRNA
coding regions are required for incorporation of the
corresponding segments into virions (Fujii et al., 2003,
2005; Watanabe et al., 2003). Our results further support
the existence of a selective mechanism of packaging for the
PB2 segment as well. Two types of mechanisms by which
these sequences could be involved in packaging the vRNAs
have been proposed by Fujii et al. (2003). In the
intersegmental association model, specific vRNA–vRNA
interactions occur through base pairing, leading to the
formation of a multisegmental macromolecule for incorpo-
ration into particles; in the protein recruitment model, the
terminal sequences of vRNAs are specifically recognized
by some viral and/or cellular protein(s) promoting their
incorporation into virions. In the intersegmental association
model, increased stability of base pairing between the PB2
vRNA and another vRNA segment in proportion with the
length of the sequences at the extremities could account for
the relative fitness of the PB2-Flag-70, PB2-Flag-95 and
PB2-Flag-143 viruses. Obviously however, more studies
are required to test this model.
Unlike the PB2-Flag viruses discussed above, Flag-PB2
viruses expressing a PB2 protein fused with the Flag
peptide at the N-terminus were readily isolated, using a
pPolI-PB2 plasmid in which the sequence encoding Flag
had been inserted at the junction between the 3VNCR and
PB2-ORF without any duplication of the PB2-ORF. As a
result, the 3V end of the PB2 segment was identical to the wt
for the 27 noncoding terminal nucleotides only. 117-Flag-
PB2 and 165-Flag-PB2 viruses were also produced,
harboring a PB2 segment identical to the wt for the 117
and 165 terminal 3V nt, respectively. The growth character-
istics of the Flag-PB2, 117-Flag-PB2 and 165-Flag-PB2
viruses were very similar, and close to those observed for
the wt virus. All three viruses remained genotypically
stable for up to 5 passages at low m.o.i. on MDCK cells.
These data suggested that conservation of the 27 non-
coding nucleotides at the 3V end of the segment could be
sufficient for efficient replication and packaging of the
PB2 segment. However, incorporation into virions of
PB2(27)GFP(166) minigenomes possessing only the 27
3V terminal nt from the PB2 segment was undetectable,
whereas their PB2(159)GFP(166) counterparts possessing
the 159 terminal 3V nt from the PB2 segment were
significantly incorporated into infectious viral particles.
The apparent discrepancy between the viral rescue
experiments and the minigenome experiments may be
explained as follows: (a) the sequence encoding the N-terminal domain of PB2 (nt 28 to 159) contains some
signal(s) which promotes incorporation of the PB2 segment
into virions, as indicated by the minigenomes experiments;
(b) this sequence is present in the PB2 segment of Flag-PB2
as well as 117-Flag-PB2 and 165-Flag-PB2 viruses; and (c)
the packaging signal(s) remains functional although it is not
adjacent to the 3V noncoding extremity, thus contributing to
the efficient rescue of infectious Flag-PB2 viruses. On the
whole, our data suggest that both the 5V and 3V ends of the
PB2 coding sequence contain packaging signals, but that the
5V packaging signal is impaired when separated from the
5VNCR by the Flag sequence, whereas the 3V packaging
signal does not need to be adjacent to the 3VNCR. Yet
another possibility is that the presence of the 27 noncoding
nt at the 3V end of the PB2 segment is actually enough to
direct efficient incorporation of PB2 vRNA, but that the
GFP sequence interferes with the packaging process when
placed immediately next to the 3V noncoding extremity in
the minigenome experiments.
Given our success in producing viruses which expressed
a PB2 protein fused to the Flag tag, we attempted to
generate recombinant WSN viruses expressing a PB2
protein fused to the GFP protein. Such viruses would
have been very useful tools to understand both early and
late stages of the viral cycle, by real-time follow-up of
RNPs trafficking. The appropriate pPolI constructs were
designed so that the GFP-PB2 and PB2-GFP encoding
vRNAs would have their terminal 3V and 5V sequences,
respectively, identical to the wt for 159 and 166 nt,
respectively. Such extremities could ensure efficient
replication and incorporation of the vRNA into virions,
as shown by our experiments with PB2(159)GFP(166)
minigenomes. However, no GFP-PB2 or PB2-GFP
expressing viruses could be rescued. Due to its increased
length (720 nt) as compared to the Flag sequence (24 nt),
the GFP sequence might interfere more negatively with
packaging signals of the PB2 segment. The low activity of
the polymerase complex including a GFP-PB2 or PB2-GFP
fusion protein (30 and 10% as compared to the wild-type
polymerase complex, respectively) could also be limiting
the efficiency of rescue and/or virus viability. Remarkably,
however, the Flag-PB2 or PB2-Flag-143 viruses replicated
almost as efficiently as the wild-type virus although they
expressed polymerase complexes with a lower activity (30
and 50%, respectively) as compared to the wild-type virus.
We examined the effect of the large size of GFP-PB2 and
GFP-PB2 segments on virus growth characteristics. We
found that virus PB2-stop-GFP-166 with a 3205 nt-long
PB2 segment (137% the length of the wt PB2 segment)
could be rescued, but showed reduced growth capacities as
compared to the wt, although it expressed a wt PB2
protein. On the other hand, virus PB2-Flag-143 with a
2485 nt-long PB2 segment (106% the length of the wt PB2
segment) had growth characteristics very similar to the wt
virus. Thus, the mechanisms involved in replication and
assembly of influenza viruses tolerate an increase of up to
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segments, albeit some detrimental effects on viral growth
were observed for a 37% but not a 6% increase. We were
initially concerned by the fact that even a short sequence
insertion into PB2 vRNA could interfere with the process
of encapsidation with the NP protein. Based on a report by
Ortega et al. (2000) suggesting that the NP protein interacts
as a dimer with 48 nt, most pPolI-PB2 constructs used in
the present study were designed so that the length of the
corresponding RNAs was increased by a multiple of 48 nt
as compared to the wt PB2 segment. However, the Flag-
PB2 virus had by definition a PB2 vRNA 30 nt longer than
the wt virus. Furthermore, while trying to isolate a
recombinant PB2-GFP-stop-166 virus, we unexpectedly
obtained a virus with a PB2 vRNA 248 nt (5  48 + 8 nt)
longer than the wt virus, as a result of the deletion of part
of the GFP coding sequence (data not shown). Both the
Flag-PB2 and GFP-deleted viruses grew as efficiently as
the wt virus, which argues against the possibility that an
increase in length according to the rule of 48 nt could be
critical with respect to the replicative potential of the PB2
vRNA of influenza virus.
On the whole, our data provide information regarding
both the possibility to fuse a peptide at the N- or C-terminus
of the PB2 protein, and the signals and length constraints
involved in replication and packaging of the PB2 segment,
which may be useful for the purpose of engineering
influenza RNAs in the future.Materials and methods
Cells and virus
293T and COS-1 cells were grown in complete Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented with
10% fetal calf serum (FCS). MDCK cells were grown in
modified Eagle’s medium supplemented with 5% FCS.
Influenza virus A/WSN/33 (WSN, H1N1) was kindly
provided by Dr. Peter Palese (Mount Sinaı¨ School of
Medecine, New York, USA). Viral stocks were produced by
serial allantoic passage on 11-day-old embryonated hen’s
eggs.
Plasmids
The series of eight pPolI plasmids containing the
sequences corresponding to the genomic segments of
WSN virus, cloned under the control of the human RNA
polymerase I promoter and upstream of the hepatitis y
ribozyme sequence (Fodor et al., 1999), were kindly
provided by Dr. G. Brownlee (Sir William Dunn School
of Pathology, Oxford, UK). In order to insert the Flag
sequence downstream the PB2-ORF into the pPolI-PB2
plasmid, two PCR reactions were performed in parallel,
using pPolI-PB2 as a template, and oligonucleotides5VTGGATTATCAGAAACTGGGAAAC-3V and 5VGTCGQ
TCATCGTCTTTGTAGTCAGCTGCATTGATGGC-
CATCCGAATTCTTTTGGTCG-3V on the one hand,
5VCATCAATGCAGCTGACTACAAAGACGATGACGA-
CAAATAGTGTCGAATAGTTTAAAAACGACCTTG-3V
and 5VCAGCTGGCGAAAGGGGGATGTGC-3V on the
other hand. An equimolar mix of the amplified products
was used as a template for a third PCR reaction, with oligo
nucleotides 5VTGTACAATAAAATGGAATTTGAGC-3V
and 5VCGACGTTGTAAAACGACGGCCAG-3V. The
resulting amplicon was cloned between the BstXI and SphI
sites of plasmid pPolI-PB2. The pPolI-PB2-Flag-70 plasmid
was obtained using the same strategy, except for the fact that
the third oligonucleotide mentioned above was replaced
with oligonucleotide 5VGACTACAAAGQACGATGACGA-
CAAATAGCTAGCACAGCGACCAAAAGAATTCG-3V,
designed in such a way that the resulting DNA fragment
included a NheI site (underlined) between the termination
codon and the PB2 ORF duplication. In order to generate
pPolI-PB2-Flag-95 and pPolI-PB2-Flag-143 plasmids, a
single PCR reaction was performed using pPolI-PB2 as a
template, and oligonucleotides 5VATGCGCTAGCCTC-
TAGCATACTTACTGACAGCCAG-3V and 5VATGCQ
GCTAGCGCTAATTGGGCAAGGAGACGTGGTG-3V,
respectively, in combination with oligonucleotide 5VCGACQ
GTTGTAAAACGACGGCCAG-3V. The resulting ampli-
cons were cloned between the NheI and SphI sites of
plasmid pPolI-PB2-Flag-70. The pPolI-PB2-derived plas-
mids of the Flag-PB2, PB2-GFP and GFP-PB2 series were
obtained using similar strategies as for the PB2-Flag series.
Plasmid pEGFP-N1 (Clontech) was used as a template to
amplify the sequence encoding the GFP. Sequences of the
oligonucleotides can be obtained upon request.
In order to construct the pPolI-PB2(27)GFP(34) plasmid,
the GFP sequence was cloned in positive sense orientation
into the PolI expression plasmid pPR7, which contains a
truncated human RNA polymerase I promoter and the
hepatitis y virus ribozyme sequence (Crescenzo-Chaigne et
al., 1999). The whole GFP coding sequence was amplified
using plasmid pEGFP-N1 as a template and oligonucleotides
BsaI/PB2/+/3VNCR and BsaI/PB2//5VNCR which included
nucleotides corresponding to the 3V and 5VNCR of the PB2
segment, respectively, and a BsaI restriction site. The
amplified products were digested with BsaI and then cloned
between the two BbsI sites of plasmid pPR7, yielding plasmid
pPolI-PB2(27)GFP(34). In order to generate the pPolI-
PB2(159)GFP(166) plasmid, two PCR reactions were per-
formed in parallel, using plasmids pPolI-159-GFP-PB2 and
pPolI-PB2-GFP-166 as templates, and yielding overlapping
DNA fragments corresponding to the 3V half of the 159-GFP-
PB2 vRNA and the 5V half of the PB2-GFP-166 vRNA,
respectively. An equimolar mix of the amplified products was
used as a template for a third PCR reaction, with oligonucleo-
tides BsaI/PB2/+/3VNCR and BsaI/PB2//5VNCR. The result-
ing amplicon was cloned into pPR7 as described above. The
pPolI-PB2(159)GFP(34) and pPolI-PB2(27)GFP(166) plas-
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XhoI or NheI–SacI restriction fragment derived from pPolI-
PB2(159)GFP(166), respectively, between the corresponding
sites in pPolI-PB2(27)GFP(34). Sequences of the oligonu-
cleotides can be obtained upon request.
The recombinant pcDNA3.1 plasmids for the expression
of WSN-PB1, -PB2, -PA and -NP proteins (pcDNA-WSN-
PB1, -PB2, -PA, and -NP) (Fodor et al., 1999) were kindly
provided by Dr. G. Brownlee. The pcDNA3.1 plasmids for
expression of PB2 fusion proteins were constructed in two
steps. First, an AgeI restriction site was inserted at the
HindIII site of plasmid pcDNA3.1 (Invitrogen). The PB2
inserts (obtained by digestion of pPolI-PB2 plasmids with
NgoMIV) were subcloned at the AgeI site into the resulting
plasmid. Plasmid pPR7-FluA-CAT has been described
earlier (Crescenzo-Chaigne et al., 1999).
All constructs were verified by the sequencing of positive
clones using a Big Dye terminator sequencing kit and an
automated sequencer (Perkin Elmer).
Analysis of PB2 fusion proteins expression in transiently
transfected cells
For Western blot assays, total cell extracts were used. At
48 h following transfection with 6 Ag of a recombinant
pcDNA3.1-PB2 plasmid and 10 Al of the Fugene 6
transfection reagent (Roche), cells were resuspended directly
in 300 Al of sample loading buffer. Cell extracts were loaded
on a 8 or 10% polyacrylamide gel, and Western blotting was
performed as described previously (Naffakh et al., 2000). The
rabbit antiserum directed against the PB2 protein of A/
Victoria/3/75 virus was kindly provided by J. Ortin (Uni-
versidad Autonoma de Madrid, Spain) and was diluted 1/
5000. The M2 anti-Flag (SIGMA) and GL8 anti-GFP
(BioScience) monoclonal antibodies were diluted 1/10,000.
Following incubation with peroxidase-conjugated secondary
antibodies (donkey anti-rabbit-peroxidase or sheep anti-
mouse-peroxidase, 1/10,000 dilution, Amersham), the spe-
cific bands were visualized with enhanced chemilumines-
cence (ECL+ system, Amersham) and by autoradiography.
For transient transcription/replication assays, a mixture
of plasmids pcDNA3.1-PB1, -PB2, -PA, -NP (1, 1, 1, 2 Ag)
and pPR7-FluA-CAT (1 Ag) was transfected into a subcon-
fluent monolayer of COS-1 cells (3  105 cells in a 35-mm
dish) using 10 Al of the Fugene-6 transfection reagent
(Roche). At 24 h post-transfection, COS-1 cells were
washed with PBS, and lysed in 500 Al of the Lysis Buffer
provided with the CAT ELISA Kit (Roche). The lysates
were clarified by centrifugation at 14,000 rpm at 4 -C for 10
min, and tested for CAT levels using the kit mentioned
above, which allowed detection of 0.05 ng/ml CAT.
Production of recombinant viruses by reverse genetics
The method used for the production of recombinant
influenza viruses by reverse genetics was adapted frompreviously described procedures (Fodor et al., 1999; Neu-
mann et al., 1999). Briefly, the eight pPolI and 4 pcDNA3.1
plasmids (1 Ag of each) were co-transfected into a
subclonfluent monolayer of cocultivated 293T and MDCK
cells (4  105 and 3  105 cells, respectively, in a 35-mm
dish), using 10 Al of the Fugene 6 transfection reagent
(Roche). After 24 h of incubation at 35 -C, the supernatant
was removed and replaced with DMEM supplemented with
2% FCS, and the cells were incubated at 35 -C for two more
days. The efficiency of reverse genetics was evaluated by
titrating the supernatant on MDCK cells, in a standard plaque
assay using an agarose overlay in complete MEM with 2%
FCS. Subsequent passages of the recombinant viruses were
performed at an m.o.i. of 0.001 on MDCK cells for 3 days at
35 -C in DMEM supplemented with 2% FCS.
Viral RNA extraction, RT-PCR and sequence analysis
Viral RNA was extracted using the QIAamp Viral RNA
Mini kit (Qiagen) from 140 Al of cell-free supernatant,
according to the manufacturer’s recommendations. The RNA
was eluted in 50 Al of RNAse-free water, and 5 Al was
subjected to reverse-transcription and amplification using the
SuperScript One-Step RT-PCR kit (Invitrogen), and oligo-
nucleotides 5VTGTACAATAAAATGGAATTTGAGC-3V
(PB2/+/1772) and 5VAGTAGAAACAAGGTCGTTTQ
TTAAAC-3V (PB2//5VNCR), or 5VAGCGAAAGCAGGT-
CAATTATATTC-3V (PB2/+/3VNCR) and 5VCCACTCGQ
TTAGGQGAAAACAACTTCC-3V (PB2//517), to amplify
the 5V or 3V end of the PB2 segment, respectively. A fraction of
the RT-PCR products was analyzed on a 1% agarose gel and
visualized by ethidium bromide staining. The remaining was
purified using a QIAquick PCR purification kit (Qiagen), and
the sequence was determined using internal oligonucleotides,
a Big Dye terminator sequencing kit and an automated
sequencer (Perkin Elmer).
Indirect immunofluorescence assay
MDCK cells on coverslips were infected with wt virus or
with the PB2-Flag-143 or Flag-PB2 recombinant virus, at an
m.o.i. of 10. At 6 h post-infection, cells were fixed with PBS-
4% paraformaldehyde for 20 min, permeabilized with PBS-
0.5% Triton X100 for 15 min and then incubated with either
the M2 anti-Flag (SIGMA) or IA-52 anti-NP (Oxford
Biotechnology) monoclonal antibody, diluted 1/250 and 1/40,
respectively. After subsequent incubation with a fluorescein
coupled anti-mouse IgG secondary antibody (PharMingen,
diluted 1/200), the samples were analyzed under a fluorescence
microscope (Leica).
Analysis of the efficiency of packaging of PB2 minigenomes
Each of the pPolI-PB2(nn)GFP(nn) plasmids (2 Ag) was
transfected into a subconfluent monolayer of COS-1 cells
(3  105 cells in a 35-mm dish), using 6 Al of the Fugene 6
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-C, the supernatant was removed, the transfected cells were
superinfected with WSN virus at an m.o.i. of 2 or 0.02 and
then incubated for 24 or 48 h, respectively, at 35 -C. Both
the cells and supernatant were harvested. The cells were
trypsinized, washed twice in PBS, fixed in PBS containing
1% paraformaldehyde and analyzed for fluorescence inten-
sity on a FACScalibur fluorocytometer (Becton Dickinson).
The supernatants were clarified by centrifugation, and used
undiluted to infect subconfluent monolayers of MDCK cells
(106 cells in 35-mm dishes). At 24 h post-infection, MDCK
cells were analyzed for fluorescence intensity as described
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